Ramosetron Does Not Reduce the Analgesic Efficacy of Tramadol after Gynecological Laparoscopic Surgery
Table 1
Patients’ characteristics and anesthesia data.
Ramosetron (n=49)
Control (n=51)
P value
N (%) or median (min-max)
Age (years)
47 (23-60)
46 (24-64)
0.893
Weight (Kg)
55 (45-70)
57 (46-101)
0.324
Duration of surgery (min)
95 (30-220)
105 (30-380)
0.541
Duration of anesthesia (min)
130 (60-285)
145 (65-420)
0.638
Amount of infused remifentanil
496.5 (206-1334)
527 (161-2088)
0.526
Amount of infused propofol
945 (190-2800)
1160 (481-3515)
0.169
PONV scores 1h postoperatively
0
44 (89.8)
48 (94.1)
0.713
1
4 (8.2)
2 (3.9)
2
1 (2.0)
1 (2.0)
PONV scores 24h postoperatively
0
27 (55.1)
23 (45.1)
0.542
1
7 (14.3)
7 (13.7)
2
11 (22.4)
18 (35.3)
3
4 (8.2)
3 (5.9)
ASA
Status I
40 (81.6)
32 (62.7)
0.036
Status II
9 (18.4)
19 (37.3)
Satisfaction
dissatisfied
1 (2.0)
2 (4.0)
0.881
(missing =1)
neutral
13 (26.5)
12 (24.0)
satisfied
24 (49.0)
27 (54.0)
very satisfied
11 (22.5)
9 (18.0)
C: Chi square test, F: Fisher’s exact test, W: Wilcoxon rank sum test, PONV: postoperative nausea and vomiting, satisfaction for the overall analgesic technique.
